Feedback

Evaluation of the impact of pharmaceutical trainings and tools on the proper use of medicines in pediatrics

Affiliation
Department of Clinical Pharmacy ,Montpellier University Hospital ,Montpellier ,France
Charles, F.;
Affiliation
Department of Clinical Pharmacy ,Montpellier University Hospital ,Montpellier ,France
Castet-Nicolas, A.;
Affiliation
Paediatric Endocrinology and Mineral Bone Diseases Unit ,Montpellier University Hospital ,OSCAR Rare Diseases Network ,School of Medicine ,University of Montpellier ,Montpellier ,France
Amouroux, C.;
Affiliation
PhyMedExp ,INSERM ,University of Montpellier ,Montpellier ,France
Moreau, J.;
Affiliation
Unit of Paediatric Pulmonology and Cardiology ,Department of Paediatrics ,Montpellier University Hospital ,Montpellier ,France
Werner, O.;
Affiliation
Paediatric Nephrology Department ,SORARE Reference Centre ,Montpellier University Hospital ,School of Medicine ,University of Montpellier ,Montpellier ,France
Morin, D.;
Affiliation
Department of Public Health ,Clermont-Ferrand University Hospital ,Clermont-Ferrand ,France
Berland, P.;
Affiliation
Paediatric Nephrology Department ,SORARE Reference Centre ,Montpellier University Hospital ,School of Medicine ,University of Montpellier ,Montpellier ,France
Fila, M.;
Affiliation
Department of Clinical Pharmacy ,Montpellier University Hospital ,Montpellier ,France
de Barry, G.

Introduction: After six years of medication errors’ (MEs) collection and analysis in a pediatric unit of a French University Hospital, the number of MEs was no longer decreasing. We then decided to set up pharmaceutical training and tools and evaluate their impact on the occurrence of ME. Materials and methods: This monocentric prospective study was carried out in the form of audits of prescriptions, preparations, and administrations before and after intervention (A1 and A2). After the analysis of A1 results, feedback was given to the teams, some tools for the proper use of medication (PUM) were distributed, and A2 was conducted. Finally, A1 and A2 results were compared. Results: Each audit included 202 observations. A total of 120 MEs were identified during A1 and 54 for A2 ( p < 0.0001). The observation rate with at least 1 ME decreased from 39.11% to 21.29% ( p < 0.0001), and no observation had more than two MEs during A2 in contrast to A1 ( n = 12). Human factors were responsible for the majority of MEs. The audit feedback allowed professionals to feel concerned about ME. The PUM tools received an average satisfaction rating of 9/10. The staff had never participated in this type of training, and all felt it was useful to apply PUM. Conclusion: This study showed a significant impact of pharmaceutical training and tools on the pediatric PUM. Clinical pharmaceutic actions allowed us to reach our objectives and satisfied all the staff. They must, therefore, be continued to limit human factors’ impact and thus contribute to the safety of drug management in pediatrics.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2023 Charles, Castet-Nicolas, Amouroux, Moreau, Werner, Morin, Berland, Fila and de Barry.

Use and reproduction: